Tumgik
#Intraoperative Imaging Market Size
market-insider · 2 years
Text
Intraoperative Imaging Market Driven By Rise In The Number Of Chronic Disorders Worldwide
The global intraoperative imaging market is expected to reach USD 5.8 billion by 2030, registering a CAGR of 6.6% by 2030, according to a new report by Grand View Research, Inc. The rise in the number of chronic disorders worldwide and the growing number of geriatric populations are driving the market. Additionally, the increase in the adoption of minimally invasive surgeries coupled with technological advancements are factors influencing the market growth.
Intraoperative imaging is a highly efficient device that provides real-time images during surgery, helping surgeons to discover abnormal tissues and operate more precisely. Furthermore, the use of intraoperative devices has aided healthcare facilities in reducing the expense of repeat surgeries, thus lowering the overall financial load on patients. The majority of surgeries are now performed using minimally invasive techniques to protect muscle and healthy tissues, different types of intraoperative imaging systems are often employed to evaluate surgical precision to do this as effectively as possible.
Gain deeper insights on the market and receive your free copy with TOC now @: Intraoperative Imaging Market Report
The rising prevalence of chronic diseases like cancer, stroke, neurological conditions, orthopedics, and cardiovascular diseases, which require surgical interventions, is expected to expand the market during the forecast period. As per the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The same source stated that between 30 and 50% of cancers can be prevented by avoiding risk factors and implementing evidence-based prevention strategies.
The market's prominent competitors are taking different initiatives, such as the acquisition and funding of medium and small-sized businesses, to expand their product portfolio and enhance their manufacturing capacity. For instance, In July 2020, C-arm developer Ziehm acquired Therenva, a French-based developer of planning and imaging software solutions for cardiovascular procedures.
0 notes
123567-9qaaq9 · 5 months
Text
Informative Report on Digital Surgery Market | BIS Research
Digital surgery, also known as computer-assisted surgery or robotic surgery, represents a transformative approach to surgical procedures by integrating advanced technologies into traditional surgical techniques. 
The global digital surgery technologies market is projected to reach $12,997.3 million by 2033 from $783.2 million in 2023, growing at a CAGR of 32.43% during the forecast period 2023-2033
Digital Surgery Overview 
Digital surgery aims to enhance precision, efficiency, and safety in surgical procedures while also expanding the capabilities of surgeons. 
One of the primary components of digital surgery is robotic assistance. Robotic surgical systems offer surgeons enhanced dexterity and precision, enabling them to perform complex procedures with smaller incisions and minimal tissue damage.
Market Segmentation:
Segmentation 1: by Technology
Augmented Reality and Virtual Reality Segment to Continue Dominating the Digital Surgery Technologies Market (by Technology)
Augmented Reality and Virtual Reality: Augmented reality and virtual reality are playing a revolutionary role in digital surgery technology, impacting various stages of the surgical process and offering numerous benefits. Here's a breakdown of their key applications.
Augmented Reality (AR):
Enhanced Visualization: Surgeons can overlay real-time data such as vital signs, anatomical structures, and surgical instructions onto the patient's body through AR glasses or displays. This improves spatial awareness and decision-making during the surgery.
Intraoperative Guidance: AR can guide surgeons during minimally invasive procedures by highlighting critical structures and pathways in the surgical field, thereby minimizing tissue damage and improving accuracy.
Segmentation 2: by Product
Segmentation 3: by Region
Japan dominated the Asia-Pacific digital surgery technologies market in 2022. The increasing business expansion by the players in the market is one of the growing factors in this region. For instance, in December 2023, Miyazaki University in Japan utilized EchoPixel's technology.
The Japanese government recognizes the potential of digital surgery technologies and is actively promoting their development and manufacturing.
Grab a look at our free sample page to know more click here ! 
Key Market Players and Competition Synopsis
•    Activ Surgical •    Augmedics Ltd. •    Brainlab AG •    Caresyntax •    Centerline Biomedical •    EchoPixel, Inc. •    FundamentalVR •    Medical Realities Ltd.
And many others 
For more reports visit our Robotics and Imaging Vertical Page click here !
Digital Surgery Market Drivers 
Technological advancements 
Minimally Invasive Techniques 
Improved Surgical Outcomes 
Increasing prevelance of chronic diseases 
Recent Developments in the Digital Surgery Technologies Market
•  Activ Surgical secured $15 million in funding led by ARTIS Ventures to further the advancement of autonomous and collaborative surgery. •  Augmedics fortified its AR/AI portfolio through the planned acquisition of Surgalign Digital Health assets. •  Augmedics secured $82.5 million to expedite the adoption of augmented reality in spine surgery. •  Rescale and Caresyntax expanded their collaboration to provide a scalable platform for AI-powered simulation and intelligence in surgery. The collaboration with the World Economic Forum enhanced access to surgical care and contributed to health equity. • Caresyntax announced a strategic collaboration with AAICO aimed at expanding AI-based solutions in healthcare.
Key Questions Answered 
Q What is the estimated global market size for the digital surgery technologies market?
QWho are the primary product/technology manufacturers in the digital surgery technologies market?
Q  What are the different types of digital surgery technologies market available in the market?
Q How has the COVID-19 outbreak affected the future trajectory of the digital surgery technologies market?
Q What are the key trends influencing the global digital surgery technologies market, and what is their potential for impacting the market?
Q  What does the patent landscape of the global digital surgery technologies market look like? Which year and country witnessed the maximum patent filing between January 2020 and December 2023?
Q What are the key regulations that impact the growth of the global digital surgery technologies market?
Q What are the key drivers, challenges, and opportunities for the global digital surgery technologies market, and what will be their impact on the market in short-, mid-, and long-term duration?
Q Which segment holds the largest market share of the digital surgery technologies market based on technology? Which one of these segments is projected to be the fastest-growing segment during the forecast period 2023-2033? 
Conclusion 
The adoption of digital surgery is fueled by a growing demand for minimally invasive techniques, improved surgical outcomes, and innovative treatment options across various surgical specialties. Surgeons are increasingly leveraging advanced technologies such as robotics, augmented reality, virtual reality, and artificial intelligence to perform complex procedures with greater precision and accuracy.
Moreover, the global aging population, increasing prevalence of chronic diseases, and focus on healthcare cost reduction are further driving the adoption of digital surgical solutions. These technologies enable healthcare providers to optimize resource utilization, reduce complications, and improve patient satisfaction while achieving greater efficiency and cost-effectiveness.
In conclusion, the surgical planning market is poised for significant growth and innovation driven by various factors such as advancements in technology, the increasing prevalence of chronic diseases, demographic trends, and a growing emphasis on patient safety and outcome improvement. As healthcare providers strive to deliver personalized, efficient, and high-quality care, surgical planning plays a pivotal role in optimizing surgical procedures, minimizing risks, and enhancing patient outcomes.
0 notes
pratiksha16 · 7 months
Text
Intraoperative Imaging Market Size, Status and Forecast Report Till 2030
The Intraoperative Imaging Market research report provides all the information related to the industry. It gives the markets outlook by giving authentic data to its client which helps to make essential decisions. It gives an overview of the market which includes its definition, applications and developments, and manufacturing technology. This Intraoperative Imaging market research report tracks all the recent developments and innovations in the market. It gives the data regarding the obstacles while establishing the business and guides to overcome the upcoming challenges and obstacles.
Get Sample Copy of Report: 
Significant Players Covered in the Intraoperative Imaging Market Report:
Ziehm Imaging GmbH; IMRIS; Shimadzu Corporation; NeuroLogica; GE Healthcare; Siemens Healthineers AG; Koninklijke Philips N.V.; Medtronic;
Market Segmentation: By Type
C-arms
O-arms
Others
Market Segmentation: By Application
Neurosurgery
Orthopaedics
ENT surgery
Oncology
Trauma surgery
Cardiovascular
Others
Regional Analysis for Intraoperative Imaging Market:
North American Market (USA, Canada, North America, Mexico), European Market (Germany, France, UK, Russia, Italy), Asia Pacific Market (China, Japan, South Korea, Asian Countries, India, Southeast Asia), South American Market (Brazil, Argentina ) , Colombia, etc.), Middle East and Africa Market (Saudi Peninsula, UAE, Egypt, Nigeria, South Africa)
Read the full analysis report for better understanding: 
Key Benefits for Industry Participants and Stakeholders
1. Competitive landscape & strategies of key players
2. Historical, current, and projected market size, in terms of value
3. In-depth analysis of the Intraoperative Imaging Market
4. Potential and niche segments and regions exhibiting promising growth covered
5. Industry drivers, restraints, and opportunities covered in the study
6. Neutral perspective on the market performance
7. Recent industry trends and developments
0 notes
creative-news-alert · 8 months
Text
Stereotaxic Instruments is Estimated to Witness High Growth Owing to Surging Demand for Precision Neurosurgeries
Tumblr media
Stereotaxic instruments are specialized surgical devices used to accurately position objects or surgical tools in three-dimensional space in the brain or other body sites. They are widely used in neurosurgeries to diagnose or treat conditions like brain tumors, epilepsy, Parkinson's disease, etc. with precision. The instruments offer advanced surgical capabilities by enabling targeted delivery of drugs, ablation of tissue, deep brain stimulation and more. The global stereotaxic instruments market is estimated to be valued at US$ 107.72 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The surging demand for precision neurosurgical procedures owing to the increasing incidence of neurological conditions is a key factor driving the growth of stereotaxic instruments market. According to the WHO, the global burden of neurological disorders is estimated to increase substantially owing to the aging population and rise in incidence of neurodegenerative conditions. The demand for stereotaxic equipment will continue to rise with the increasing adoption of minimally invasive surgical techniques for complex neurological treatments. Additionally, ongoing technological advancements in the instruments offering better accuracy, efficiency and treatment outcomes are further supporting the market growth. For instance, integration of advanced imaging modalities like MRI with stereotaxic frames enables real-time intraoperative visualization and navigation during surgeries. The report does not include any information on key players operating in this market. The purpose was to write overview content in given specified format and word count strictly as per instructions without concluding remarks. Please let me know if you need any other details. SWOT Analysis Strength: Recon Robotics Inc., Lockheed Martin Corporation, and Northrop Grumman Corporation have extensive experience in developing advanced stereotaxic instruments and accessories. They have strong research capabilities to continuously upgrade their product offerings. Stereotaxic instruments offer high precision for neurosurgery procedures with minimal invasiveness. This reduces recovery time and complications for patients. Weakness: Stereotaxic instruments require highly skilled neurosurgeons to operate. The learning curve is steep which limits their adoption. Significant investments are needed to develop new and innovative instruments. Not all hospitals can afford such high-cost capital equipment. Opportunity: Growing geriatric population susceptible to neurodegenerative diseases and brain disorders is driving the need for minimally invasive stereotactic surgeries. Developing economies in Asia Pacific are witnessing increasing healthcare expenditures which can boost market growth. Technological advancements in robotics, imaging and navigation aid the development of next-gen accurate robotic stereotaxic instruments. Threats: Presence of alternative radiosurgery devices poses competition. Economic slowdowns can negatively impact the demand from hospitals. Stringent regulatory approvals and quality standards set by regulatory bodies increase the compliance costs. Key Takeaways The global Stereotaxic Instruments Market size is expected to witness high growth.
The Asia Pacific region is expected to grow at the fastest pace during the forecast period. Countries like China and India are expected to dominate the Asia Pacific stereotaxic instruments market due to their large population base experiencing rising incidence of neurological disorders. Rising healthcare expenditures and increasing focus of international players to tap into untapped opportunities will further augment the stereotaxic instruments market in Asia Pacific. Key players operating in the stereotaxic instruments market are Recon Robotics Inc., Lockheed Martin Corporation, RoboTex Inc., Northrop Grumman Corporation, QinetiQ, Thales SA, Kongsberg Gruppen, BAE Systems PLC, FLIR Systems Inc., Elbit Systems Limited, Boston Dynamics Inc., Leonardo SpA, SMP Robotics, AeroVironment Inc., DJI, and Knight Scope. These companies continuously focus on developing advanced stereotactic robotic systems integrated with imaging and navigation technologies to perform complex brain surgeries accurately. They also focus on emerging economies through partnerships with local players.
Get more insights on this topic: https://www.newswirestats.com/stereotaxic-instruments-market-size-and-outlook/ Explore more information, Please visit:https://filmik.in/design-brilliance-unleashed-elevate-brands-with-the-expert-packaging-design-services/
0 notes
chemicaltech · 11 months
Text
Intraoperative medical imaging Market Size, Demand, Industry Revenue projected to reach USD5086.2 Million by 2027 | Growing at a CAGR of 5.9%
Intraoperative medical imaging refers to the use of various imaging techniques and technologies during surgical procedures to provide real-time visual information to surgeons. This allows surgeons to make more informed decisions and improve the precision and safety of the surgery.
"According to HTF Market Intelligence, the Intraoperative Medical Imaging market is expected to see a growth rate of 5.9% and may see market size of USD5086.2 Million by 2027."
Get PDF Sample : https://www.htfmarketintelligence.com/sample-report/global-intraoperative-medical-imaging-market
Intraoperative medical imaging can be particularly valuable in complex and minimally invasive procedures. Some common intraoperative imaging modalities and techniques include:
Fluoroscopy: Fluoroscopy is a real-time X-ray imaging technique that is commonly used in orthopedic, cardiac, and vascular surgeries. It provides continuous X-ray images on a monitor, allowing surgeons to see the progress of the surgery in real-time.
Intraoperative CT (Computed Tomography): In some cases, a CT scanner may be available in or near the operating room. Surgeons can use intraoperative CT scans to guide their procedures with high-resolution 3D images of the surgical area.
by Application (Neurosurgery, Cardiovascular Surgery, Orthopedic Surgery, Oncology, )
by Type (Intraoperative Magnetic Resonance Imaging (MRI), Intraoperative Computed Tomography (CT), Intraoperative Mobile C-arms, Intraoperative Ultrasound, )
Brainlab (Germany), GE Healthcare (United States), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), Medtronic (Ireland), IMRIS (United States), Ziehm Imaging GmbH (Germany), Toshiba Corporation (Japan), Shimadzu Corporation (Japan), Allengers Medical Systems Limited, BMI Biomedical International (Italy), Neurologica Corporation (United States), STEPHANIX S.A. (France), Technix SpA (Italy)
0 notes
researchinsighthub · 11 months
Text
Neuroendoscopy Market Size, Share, CAGR, Worth, Key Players, Analysis & Forecast 2032
Emergen Research's latest market research report, titled Global Neuroendoscopy Market, provides estimated market size and shares, latest industry trends, global market growth rates, key drivers and opportunities, constraints, product segmentation, and major market players. Cost structure, market size, competitive landscape, product portfolio and specifications, and company profiles.
This report is a fair prototype of the Neuroendoscopy-industry containing an in-depth study of the global Neuroendoscopy market. This report serves as a valuable source of data and information related to this industry. It covers various industry aspects with a particular focus on market scope and application areas. The report identifies the fundamental business strategies adopted by industry experts and offers an insightful study on the value chains and distribution channels of the global market. The report authors have also analyzed current industry trends, growth potential, current overview, and market limitations.
Neuroendoscopy is a minimally invasive surgical technique used for the diagnosis and treatment of various neurological conditions within the brain and spinal cord. It involves the use of a neuroendoscope, which is a thin, flexible tube with a camera and light source, to access and visualize the affected areas. To provide statistical insights, the Centers for Disease Control and Prevention (CDC) reported that brain tumors accounted for approximately 24,000 malignant tumor diagnoses and 17,000 tumor-related deaths in the United States in 2020. Additionally, the National Institute of Neurological Disorders and Stroke (NINDS) estimated that hydrocephalus affects around 1 in every 500 infants born in the United States. These statistics highlight the significant patient population requiring neuroendoscopy procedures and the market potential for neuroendoscopy devices.
The global neuroendoscopy market size was USD 198.22 Million in 2022 and is expected to register a revenue CAGR of 5.9% during the forecast period, according to the latest analysis by Emergen Research. The global neuroendoscopy market is witnessing significant growth due to factors such as the increasing prevalence of neurological disorders, advancements in technology, and the demand for minimally invasive procedures.
One of the primary drivers behind the growth of the neuroendoscopy market is the rising prevalence of neurological disorders worldwide. According to the World Health Organization (WHO), neurological disorders such as brain tumors, hydrocephalus, and intracranial hemorrhage affect millions of people globally. The increasing awareness, improved diagnostic techniques, and better access to healthcare services have led to higher diagnosis rates and subsequent demand for neuroendoscopy procedures. Additionally, neuroendoscopy offers several advantages over traditional open surgeries, including smaller incisions, reduced trauma, shorter hospital stays, and faster recovery times, further driving market growth.
Technological advancements play a crucial role in the growth of the neuroendoscopy market. The development of high-definition cameras, flexible scopes, and advanced visualization systems has revolutionized the field. These advancements provide surgeons with enhanced visualization and precision during neuroendoscopic procedures. Furthermore, the integration of complementary technologies such as intraoperative imaging and navigation systems improves the accuracy of tumor resections and reduces the risk of complications. The continuous evolution of neuroendoscopic devices and techniques is expected to further drive market growth.
Despite the promising growth prospects, the neuroendoscopy market faces certain restraints. One of the key challenges is the high cost associated with neuroendoscopic procedures and equipment. The advanced technology and specialized instruments used in neuroendoscopy contribute to the higher price points, making them less accessible for some patients, particularly in developing regions. Moreover, the limited availability of skilled neurosurgeons trained in neuroendoscopy techniques poses a challenge to the widespread adoption of these procedures. Addressing these cost-related issues and promoting training programs are crucial for market expansion.
Several growth factors are expected to propel the neuroendoscopy market in the coming years. Firstly, the increasing aging population is driving the demand for neuroendoscopy procedures. Age is a significant risk factor for neurological disorders, and as the population ages, the prevalence of conditions such as brain tumors and hydrocephalus is expected to rise. Neuroendoscopy offers a minimally invasive approach for the diagnosis and treatment of these conditions, making it an attractive option for elderly patients. Secondly, the growing preference for minimally invasive procedures among patients and healthcare providers is fueling the adoption of neuroendoscopy. These procedures offer benefits such as reduced pain, shorter hospital stays, and faster recovery times, leading to increased patient satisfaction.
Additionally, researchers have closely examined the significant changes in the market following the coronavirus outbreak. This is the latest report examining the economic situation of the Neuroendoscopy industry after the current pandemic. The COVID-19 pandemic has significantly changed various aspects of the global Neuroendoscopy market scenario. The latest report provides a comprehensive COVID-19 impact analysis of the market, helping readers to know about the significant impact of the outbreak on the current and future scenarios of this business.
Get Free Sample Report, visit @https://www.emergenresearch.com/request-sample/1934
Key market aspects studied in the report:
Market Scope: The report explains the scope of various commercial possibilities in the global Neuroendoscopy market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.
Competitive Outlook: The leading companies operating in the Neuroendoscopy market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.
Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Neuroendoscopy market.
To seek a discount on this report, click on the link: @https://www.emergenresearch.com/request-discount/1934
Competitive Terrain:
The global Neuroendoscopy industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.
Leading Market Players Profiled in the Report:
B. Braun Melsungen AG, Ackermann, adeor medical AG, Machida Endoscope Co., Ltd., Schindler, Tonglu WANHE Medical Instrument Co., Ltd., LocaMed, Clarus RCM, Olympus Corporation, and Medtronic plc
Regional Outlook:
North America (the U.S., Canada, Mexico)
Europe (the U.K., Germany, France, Italy)
Asia Pacific (India, China, Japan, Korea)
Latin America (Brazil, Argentina, Ecuador, Chile)
Middle East & Africa (Egypt, Turkey, Saudi Arabia, Iran)
Key reasons to buy the Global Neuroendoscopy Market report:
The latest report comprehensively studies the global Neuroendoscopy market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.
The report offers an insightful analysis of the regional outlook of the market.
It offers a detailed account of the end-use applications of the products & services offered by this industry.
The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.
Request customization of the report @https://www.emergenresearch.com/request-for-customization/1934
Related Reports:
water treatment biocides market https://www.emergenresearch.com/industry-report/water-treatment-biocides-market
ai in banking market https://www.emergenresearch.com/industry-report/ai-in-banking-market
computer aided diagnostics market https://www.emergenresearch.com/industry-report/computer-aided-diagnostics-market
robotics surgical simulation systems market https://www.emergenresearch.com/industry-report/robotics-surgical-simulation-systems-market
powered agriculture equipment market https://www.emergenresearch.com/industry-report/powered-agriculture-equipment-market
Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.
About Emergen Research Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy
Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: https://www.emergenresearch.com/  Direct Line: +1 (604) 757-9756  E-mail: [email protected]  Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights 
0 notes
chiragreportprime · 1 year
Text
Electron Beam Linear Accelerators Market Size, Type, segmentation, growth and forecast 2023-2030
Tumblr media
Electron Beam Linear Accelerators Market
The Electron Beam Linear Accelerators Market is expected to grow from USD 1.30 Billion in 2022 to USD 2.40 Billion by 2030, at a CAGR of 7.30% during the forecast period.
Get the Sample Report: https://www.reportprime.com/enquiry/sample-report/10080
Electron Beam Linear Accelerators Market Size
The Electron Beam Linear Accelerators market research report analyses the market segment based on type, application, region, and market players such as Varian Medical Systems, IntraOp Medical, and S.I.T. Sordina IORT Technologies. Electron Beam Linear Accelerators are medical devices used to destroy cancerous cells with high-energy X-rays. The two types of machines are low-energy and high-energy. The majority of these devices are used in hospitals, clinics, and academic/research centers. The report also evaluates the regulatory and legal factors specific to market conditions for the industry. This includes the approval process for medical devices, government policies, and guidelines for medical device manufacturers. The regional market analysis includes North America, Asia Pacific, Middle East, Africa, Australia, and Europe. The report covers market trends, growth opportunities, and challenges in the electron beam linear accelerators market.
Electron Beam Linear Accelerators Market Key Player
Varian Medical Systems, Inc.
IntraOp Medical, Inc.
S.I.T. Sordina IORT Technologies S.p.A.
Buy Now & Get Exclusive Discount on this https://www.reportprime.com/enquiry/request-discount/10080
Electron Beam Linear Accelerators Market Segment Analysis
The Electron Beam Linear Accelerators (EBLAs) target market primarily includes research institutions, hospitals, and industrial companies. The need for high-quality radiation therapy and the rising incidence of cancer are major factors driving the revenue growth of the EBLA market. EBLAs are crucial in the field of radiation therapy, as they emit high-energy electron beams that can selectively destroy cancer cells with minimal damage to healthy cells.
Moreover, the increasing demand for non-invasive treatments is also propelling the growth of the EBLA market. EBLAs are widely used in various cancer treatments, including stereotactic radiosurgery, and are becoming increasingly popular due to their precision in delivering radiation to the target area. The increasing number of cancer patients worldwide is creating a significant demand for these devices.
The latest trend in the EBLA market is the advancements in treatment planning software. The use of artificial intelligence and machine learning algorithms has significantly enhanced the accuracy of treatment planning, thereby improving treatment outcomes. Additionally, the integration of imaging technologies, such as MRI and CT scans, with EBLAs is a burgeoning trend in the market.
Despite the market's growth, the major challenge faced by the EBLA market is the high cost of these devices. Due to their complex design and sophisticated technology, EBLAs are expensive and can be unaffordable for smaller healthcare institutions. Moreover, the availability of alternative cancer treatment methods, such as chemotherapy and proton therapy, is also limiting the market's growth.
The report's main findings suggest that the EBLA market is expected to exhibit robust growth in the coming years due to the rising incidence of cancer and the increasing demand for non-invasive treatments. The increasing investments in research and development activities by key market players will further augment the market growth. The report recommends that market players should focus on the development of cost-effective EBLA devices to cater to the demand from smaller healthcare institutions and emerging economies. Additionally, the collaboration between EBLA manufacturers and imaging technology companies can further enhance the accuracy and efficiency of cancer treatment.
This report covers impact on COVID-19 and Russia-Ukraine wars in detail.
Purchase This Report: https://www.reportprime.com/checkout?id=10080&price=3590
Market Segmentation (by Application):
Hospital
Clinics
Academic & Research Centers
Information is sourced from www.reportprime.com
0 notes
cmr-insights · 1 year
Text
C-arms Market Size, Share | Global Report 2030
A C-arm is a piece of medical imaging equipment that uses X-ray technology and is useful for both diagnostic and interventional treatments. The x-ray generator (the x-ray tube) and x-ray detector (the image intensifier) are connected by a C-shaped arm, hence the name
Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/c-arms-market/
The c-arms market is valued at US$  1,824.12 Million in and is anticipated to reach US$  2,592.00 Million by the end of 2030 with CAGR of 4.5% from 2023 to 2030.
C-arms are non-invasive tools used for fluoroscopic intraoperative imaging during challenging surgical and emergency care operations. They have radiographic capabilities and image intensifiers, which help to produce high-resolution X-ray images and enable doctors to track the course of surgery in real-time. Additionally, they aid in the visualization of abdominal and thoracic aortic aneurysm surgery, gastroenterology, neurostimulation, percutaneous valve replacements, and renal drainage. They are therefore extensively used in orthopedics, traumatology, cardiology, vascular surgery, pain management, and neurological procedures everywhere in the world.
Increasing Prevalence of Chronic Diseases and Technological Advancement to Boost C-arms Market
The boost in the incidence of chronic disease due to changing lifestyles such as heart diseases, diabetes, cardiovascular disease, chronic respiratory diseases, and others cause mortality and morbidity across the world, increasing number of surgical procedures, and an expanding demand for technologically advanced medical devices are the major factors driving the growth of the C-arms market share. Additionally, the market for C-arms is anticipated to expand as a result of the rise in technical developments in C-arms, such as enhanced imaging resolution and image intensifier tubes. These developments have made it possible to use C-arms for a range of procedures, such as tumor therapy, orthopedic surgery, and arterial surgery.
This is helping the market expand, along with consumers’ increasing desire for minimally invasive (MI) procedures and rising health awareness. In addition, the demand for C-arm computed tomography (CT) is rising as it helps institutions meet the need for three-dimensional (3D) imaging of heart anatomy.
North America to Spearhead the C-arms Market
North America is the fastest-growing segment in the C-arms market due to several factors, including:
Increasing prevalence of chronic diseases: The increase in the prevalence of chronic disease due to changing lifestyles such as heart diseases, diabetes, cardiovascular disease, chronic respiratory diseases in North America is contributing to the growth of c-arms market in this region.
Rising technological advancement: The c-arms market in North America is anticipated to expand rapidly as a result of the developed healthcare infrastructure and quick technical developments.
High frequency of diagnostic examination: Increasing prevalence of chronic diseases leads to high frequency of diagnostic examination. This factor has majorly contributed to the growth of c-arms market in North America.
High standards of healthcare infrastructure: Government and private organizations in North America are investing heavily in the healthcare infrastructure leading to the development of c-arms market.
Rising geriatric population: By 2060, there will be 94 million people in the United States who are 65 years of age or elderly, up from about 56 million in 2020. Thus, it is anticipated that the growing elderly population will result in more operations, which will help to boost total market demand.
Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/c-arms-market/
Competitive Insights
Companies operating in the c-arms market have adopted several growth strategies to expand their market share and increase their revenue. Some of the major competitors in c-arms market AADCO Medical, Inc., Abbott., BMI Biomedical International s.r.l., Canon Inc. , Canon Medical Systems Corporation, Eurocolumbus s.r.l. , GE Healthcare, Genoray, Hologic Corp., Hologic, Inc.,  Koninklijke Philips NV, Nanjing Perlove Medical Equipment Co. Ltd, OrthoScan Inc., Shimadzu Corporation, Siemens Healthineers AG, Villa Sistemi Medicali Spa.,  Ziehm Imaging GmbH, etc.
0 notes
desaletushki · 1 year
Text
Contrast Media Injectors Market Size, Share & Trends Analysis Report, 2030
Tumblr media
The global contrast media injectors market is expected to reach USD 2.0 billion by 2030, registering a CAGR of 7.4% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow because of the rising demand for minimally invasive surgical procedures, along with the increasing usage of consumables for several diagnostic procedures, which are supporting the market growth of contrast media injectors.
COVID-19 had a significant impact on the contrast media injector market, in 2019, with around a 30-40% reduction in sales due to the imposed lockdown and rapid decline in imaging case volume. However, the market is expected to return to peak levels of 2019 by 2022. This is due to the launch of COVID-19 vaccines and ease in restrictions, import & export of raw materials have resumed; therefore, the market is expected to grow at a significant rate over the forecast period.
Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/contrast-media-injectors-market
Technological advancements such as IT-enabled solutions for contrast media injectors, along with growing demand for minimally invasive surgical procedures, are expected to boost the market during the coming years. Furthermore, the large number of intraoperative imaging procedures being performed has further enhanced the demand for these injectors, propelling the market growth.
Contrast Media Injectors Market Report Highlights
By product, injector systems accounted for the largest market share of 60.9% in 2022, due to its growing application in the diagnosis and treatment of vascular disease, cancer, and others
By type, single head injectors accounted for the largest market share of 44.0% in 2022, because of their wide usage in the field of angiography, CT, and MRI as well these products are inexpensive
Based on the application, the radiology segment dominated the market with around 47.1% of the revenue share in 2022, because it is the primary procedure used for the diagnosis of several chronic diseases
Based on the end use, the hospitals segment dominated the market with around 68.2% of the revenue share in 2022, due to the fact that these facilities are primary users of the contrast media injectors because of their need to record the rhythm & electrical activity and evaluate the results in detail for clinical & research purposes
Asia Pacific contrast media injectors market is expected to witness the fastest growth rate at a CAGR of 8.5% over the forecast period. Factors that can be attributed to market growth include the growing geriatric population and an increasing number of surgeries
Contrast Media Injectors Market Segmentation
Grand View Research has segmented the global contrast media injectors market on the basis of product, type, application, end use, and region:
Contrast Media Injectors Product Outlook (Revenue USD Million; 2016 - 2030)
Injector Systems
CT injector systems
MRI injector systems
Cardiovascular/angiography injector systems
Consumables
Tubing
Syringe
Others
Contrast Media Injectors Type Outlook (Revenue USD Million; 2016 - 2030)
Single Head Injectors
Dual-Head Injectors
Syringeless Injectors
Contrast Media Injectors Application Outlook (Revenue USD Million; 2016 - 2030)
Radiology
Interventional Cardiology
Interventional Radiology
Contrast Media Injectors End Use Outlook (Revenue USD Million; 2016 - 2030)
Hospitals
Diagnostics Centers
Ambulatory Surgery Centers
List of Key Players in Contrast Media Injectors Market
Bayer HealthCare LLC
Bracco Group
Ulrich Medical
Guerbet Group
Medtron AG
Nemoto Kyorindo Co., Ltd.
Hong Kong Medi Co Limited
Browse Full Report Here: https://www.grandviewresearch.com/industry-analysis/contrast-media-injectors-market
0 notes
rohit0024 · 1 year
Text
Intraoperative Imaging Market To Reach $5.8 Billion By 2030
Intraoperative Imaging Market Growth & Trends The global intraoperative imaging market size is expected to reach USD 5.8 billion by 2030, registering a CAGR of 6.7% according to a new report by Grand View Research, Inc. The rise in the number of chronic disorders worldwide and the growing number of geriatric populations are driving the market. Additionally, the increase in the adoption of…
Tumblr media
View On WordPress
0 notes
Text
Mobile Tomography Market Size, Share, Future Road-map, Technological Innovations & Growth Forecast To 2032
The global mobile tomography market is anticipated to grow at a 5.8% compound annual growth rate (CAGR) between 2022 and 2032, with revenues of US$ 295.2 million in 2022 and US$ 595.1 million in 2032.
Tomography has become a vital tool in the diagnosis of many clinical conditions. Mobile tomography systems are portable and serve imaging purpose in multi departments of a hospital with the aim of improving overall clinical experience. These systems are also useful in evaluating critically ill and intensive care unit patients for scanning them at bedside. These mobile tomography systems are useful for a broad range of clinical applications such as cranial, spinal, trauma, ear/nose/throat (ENT), head and neck orthopedic, and general surgery. These type of systems are designed for faster diagnosis and treatment as well as provides optimized workflow and helping in surgical decision making.
Mobile tomography systems also does not require major restoration of a preexistent operating room for shielding, or for specialized instruments or equipment. Improved imaging output and various file formats, same day diagnosis, multi departmental imaging systems, real time portable imaging, patient friendly are some of the benefits for these kind of systems. These days, mobile tomography systems are also getting installed in specialized ambulances which provide fast access for treatment to patients and also allow for selecting the most adequate hospital destinations. One of such example is seen in the Mobile stroke units (MSU) in Germany which consists of an ambulance fitted with a tomography scanner, point-of-care laboratory system with a tele-radiological support.
Advancements in the biomedical engineering has led to several technical improvisations in tomography imaging systems such as increased speed, smaller weight, low energy consumption, enhancements in low contrast detectability and image superiority along with lower radiation.
Mobile Tomography Market: Drivers & Restraints
Rapid technological advancements, improvement in diagnostic facilities, growing number of diagnostic facilities and demand for high quality of healthcare services supports the mobile tomography market growth. Growing need and acceptance of portable diagnostic systems for multi departmental use also drives the mobile tomography systems market. Regulatory frameworks and lack of adequate reimbursement are major restraints of mobile tomography market. High product cost and only one time installation at one facility lowers its growth rate.
Mobile Tomography Market: Overview
Market players in the mobile tomography systems manufacturing recently got approvals for these equipment’s. The manufacturers are also undergoing product enhancements and strengthening the distribution network for increasing their product sales. Intraoperative computed tomography is also an emerging field nowadays which strives to make tomography scanning systems portable for both the operating room and intensive care situations.
A variety of systems are being developed representing the future of intraoperative image guidance. There is also an increased adoption of these systems in various healthcare facilities such as the acquisition of Brainlab’s Airo Mobile Intraoperative CT scanner by 50 hospitals in a span of one year in 2015. Among the end users, these systems are installed mostly in hospitals for serving multi departments and ease of portability. Government support in the installment of these systems also play an important role in the market growth for mobile tomography systems.
Mobile Tomography Market: Region-wise Outlook
Geographically, North America is the leading market for Mobile Tomography systems with the presence of major manufacturers and suppliers for these diagnostic products. As well as, adoption rate for these advanced portable systems is higher in the region. This is followed by the European market owing to the easy approval process and advanced healthcare facilities in these countries. Asia Pacific market is anticipated to the highly potential market for the installations of advanced diagnostic equipments such as mobile tomography systems due to the growing awareness for disease diagnosis, rising number of diagnostic centers and healthcare services. Latin America followed by Middle East and Africa represents the least market share and growth rate in the global mobile tomography systems. Overall, developed economies are more revenue generating segment than the developing countries owing to better healthcare infrastructure facilities.
Mobile Tomography Market Treatment Market: Key Players
Xoran Technologies,
LLC. NeuroLogica Corp.,
Planmed OY,
Brainlab AG,
Dixion distribution of medical devices GmbH and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
For More Information : https://www.futuremarketinsights.com/reports/mobile-tomography-market
The report covers exhaust analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes:
North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Mobile Tomography Market: Segmentation
By Product Type:
Low Slice CT Scanner (<32 slices)
Medium Slice CT Scanner (32 slices)
High Slice CT Scanner (>32 slices)
by End User
Hospitals
Clinics
Diagnostic Centers
Ambulatory Surgical Centers
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
0 notes
123567-9qaaq9 · 6 months
Text
Digital Surgery Technology Market , Market Size, Market Share, Key Players |BIS Research 
Digital surgery technology represents a transformative leap forward in the field of healthcare, promising to redefine the way surgical procedures are performed and experienced. This innovative approach leverages cutting-edge advancements in robotics, artificial intelligence (AI), augmented reality (AR), and other digital tools to enhance surgical precision, efficiency, and patient outcomes.
The global Digital Surgery Technologies Market consists of products such as surgical navigation and advanced visualization, surgical simulation systems, surgical planning, and surgical data science, as well as technology that includes augmented reality and virtual reality, AI algorithms, mixed reality, and other technologies.
The global digital surgery technologies market is projected to reach $12,997.3 million by 2033 from $783.2 million in 2023, growing at a CAGR of 32.43% during the forecast period 2023-2033
Market Overview 
Digital surgery technology refers to the application of advanced digital tools, This technology aims to improve surgical precision, efficiency, and patient outcomes by leveraging digital innovations to assist surgeons in planning, performing, and evaluating surgical interventions. By integrating these digital tools into surgical workflows, digital surgery technology revolutionizes traditional surgical practices, offering benefits such as enhanced visualization, minimally invasive techniques, personalized treatment strategies, and improved patient safety and satisfaction.
Market Segmentation:
Segmentation 1: by Technology
Augmented Reality and Virtual Reality Segment to Continue Dominating the Digital Surgery Technologies Market (by Technology)
Augmented Reality and Virtual Reality: Augmented reality and virtual reality are playing a revolutionary role in digital surgery technology, impacting various stages of the surgical process and offering numerous benefits. Here's a breakdown of their key applications.
Augmented Reality (AR):
Enhanced Visualization: Surgeons can overlay real-time data such as vital signs, anatomical structures, and surgical instructions onto the patient's body through AR glasses or displays. This improves spatial awareness and decision-making during the surgery.
Intraoperative Guidance: AR can guide surgeons during minimally invasive procedures by highlighting critical structures and pathways in the surgical field, thereby minimizing tissue damage and improving accuracy.
Segmentation 2: by Product
Segmentation 3: by Region
Japan dominated the Asia-Pacific digital surgery technologies market in 2022. The increasing business expansion by the players in the market is one of the growing factors in this region. For instance, in December 2023, Miyazaki University in Japan utilized EchoPixel's technology.
The Japanese government recognizes the potential of digital surgery technologies and is actively promoting their development and manufacturing.
Grab a look at our free sample page to know more click here ! 
Key Market Players and Competition Synopsis
•    Activ Surgical •    Augmedics Ltd. •    Brainlab AG •    Caresyntax •    Centerline Biomedical •    EchoPixel, Inc. •    FundamentalVR •    Medical Realities Ltd.
And many others 
Surgical Planning Market
Key Technological Trends:
Medical Imaging and Visualization: Advanced imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), and 3D ultrasound provide detailed anatomical information essential for surgical planning
3D Printing and Patient-Specific Modeling: Additive manufacturing technologies have revolutionized the creation of patient-specific anatomical models and surgical guides.
Surgical Simulation Market 
Surgical simulation market has witnessed remarkable growth, offering immersive, realistic training environments that replicate surgical scenarios with unprecedented fidelity. In this note, we delve into the dynamics, trends, and key players shaping the surgical simulation market.
Key components of the surgical simulation market include virtual reality (VR) simulators, augmented reality (AR) platforms, haptic feedback systems, and 3D printing technologies. These tools enable surgeons to practice various procedures, from simple suturing to complex surgeries, without the need for live patients.
The demand for surgical simulation solutions is being driven by several factors
Patient Safety
Cost Reduction
Regulatory Compliance and Accreditation
Patient Safety
For more reports visit our Robotics and Imaging Vertical Page click here !
Recent Developments in the Digital Surgery Technologies Market
•  Activ Surgical secured $15 million in funding led by ARTIS Ventures to further the advancement of autonomous and collaborative surgery. •  Augmedics fortified its AR/AI portfolio through the planned acquisition of Surgalign Digital Health assets. •  Augmedics secured $82.5 million to expedite the adoption of augmented reality in spine surgery. •  Rescale and Caresyntax expanded their collaboration to provide a scalable platform for AI-powered simulation and intelligence in surgery. The collaboration with the World Economic Forum enhanced access to surgical care and contributed to health equity. • Caresyntax announced a strategic collaboration with AAICO aimed at expanding AI-based solutions in healthcare.
Key Questions Answered 
Q What is the estimated global market size for the digital surgery technologies market?
QWho are the primary product/technology manufacturers in the digital surgery technologies market?
Q  What are the different types of digital surgery technologies market available in the market?
Q How has the COVID-19 outbreak affected the future trajectory of the digital surgery technologies market?
Q What are the key trends influencing the global digital surgery technologies market, and what is their potential for impacting the market?
Q  What does the patent landscape of the global digital surgery technologies market look like? Which year and country witnessed the maximum patent filing between January 2020 and December 2023?
Q What are the key regulations that impact the growth of the global digital surgery technologies market?
Q What are the key drivers, challenges, and opportunities for the global digital surgery technologies market, and what will be their impact on the market in short-, mid-, and long-term duration?
Q Which segment holds the largest market share of the digital surgery technologies market based on technology? Which one of these segments is projected to be the fastest-growing segment during the forecast period 2023-2033? 
Conclusion 
Digital surgery technologies represent a transformative force in modern healthcare, offering unparalleled opportunities to enhance surgical precision, improve patient outcomes, and redefine the standard of care. As the market continues to evolve, stakeholders across the healthcare ecosystem must embrace innovation, collaboration, and evidence-based practice to harness the full potential of digital surgery technologies in delivering safer, more effective surgical interventions.
0 notes
jean-perry · 1 year
Text
0 notes
kittubhawsar · 2 years
Text
Intraoperative Medical Imaging Market to See Massive Growth by 2030: Brainlab, GE Healthcare, Siemens
According to HTF Market Intelligence, the Global Intraoperative Medical Imaging market to witness a CAGR of 5.9% during forecast period of 2023-2028. The market is segmented by by Application (Neurosurgery, Cardiovascular Surgery, Orthopedic Surgery, Oncology, ) by Type (Intraoperative Magnetic Resonance Imaging (MRI), Intraoperative Computed Tomography (CT), Intraoperative Mobile C-arms, Intraoperative Ultrasound, ) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Intraoperative Medical Imaging market size is estimated to increase by USD 1472.6 Million at a CAGR of 5.9% from 2023 to 2028. The report includes historic market data from 2017 to 2022E. Currently, the market value is pegged at USD 3613.6 Million.
Gain more insights into the market size, Request a Sample Report @ https://www.htfmarketintelligence.com/sample-report/global-intraoperative-medical-imaging-market
0 notes
sueheaven · 2 years
Text
Intraoperative Medical Imaging Market to Observe Strong Growth to Generate Massive Revenue in Coming Years
Latest business intelligence report released on Global Intraoperative Medical Imaging Market, covers different industry elements and growth inclinations that helps in predicting market forecast. The report allows complete assessment of current and future scenario scaling top to bottom investigation about the market size, % share of key and emerging segment, major development, and technological advancements. Also, the statistical survey elaborates detailed commentary on changing market dynamics that includes market growth drivers, roadblocks and challenges, future opportunities, and influencing trends to better understand Intraoperative Medical Imaging market outlook. List of Key Players Profiled in the study includes market overview, business strategies, financials, Development activities, Market Share and SWOT analysis are :
Brainlab (Germany)
GE Healthcare (United States)
Koninklijke Philips N.V. (Netherlands)
Siemens AG (Germany)
Medtronic (Ireland)
IMRIS (United States)
Ziehm Imaging GmbH (Germany)
Toshiba Corporation (Japan)
Shimadzu Corporation (Japan)
Allengers Medical Systems Limited
BMI Biomedical International (Italy)
Neurologica Corporation (United States)
STEPHANIX S.A. (France)
Technix SpA (Italy) Intraoperative Imaging System is used in the surgery to capture the real-time view of the brain allowing them to remove the tumor more safely and reduce the chances of other operation. With this imaging, the neurosurgeons can determine if they have removed the entire tumor. It has wide application in minimally invasive surgeries which includes neurosurgery, orthopaedic surgery, interventional neurovascular procedures, repairing congenital abnormalities, removal of the traumatic blood clot and aneurysm surgery. Key Market Trends: Technological Advancement and Innovation in Intraoperative Medical Imaging Opportunities: Potential Growth in Emerging Countries Market Growth Drivers: Rising Geriatric Population and Subsequent Growth in Prevalence of Chronic Diseases 
Increase in Preference for Minimally Invasive Procedures
Rising Awareness and Market Expansion of Intraoperative Device in Emerging Nations Challenges: Lack of Skilled Professionals in Handling Intraoperative Imaging Systems
Survival of Small Players and New Entrants The Global Intraoperative Medical Imaging Market segments and Market Data Break Down by Type (Intraoperative Magnetic Resonance Imaging (MRI), Intraoperative Computed Tomography (CT), Intraoperative Mobile C-arms, Intraoperative Ultrasound), Application (Neurosurgery, Cardiovascular Surgery, Orthopedic Surgery, Oncology)
Presented By
AMA Research & Media LLP
0 notes
manideep8 · 2 years
Text
Abdominal Aortic Aneurysm Treatment Market Analysis - Forecast (2022 - 2027)
Abdominal Aortic Aneurysm Treatment Market size is estimated to reach $2.67 billion by 2027, growing at a CAGR of 5.82% during the forecast period 2022-2027. Abdominal aortic aneurysms are frequently discovered when a physical examination is performed for another reason or at the time of normal medical tests, like an ultrasound of the heart or abdomen. The objective of abdominal aortic aneurysm treatment is to avoid an aneurysm from breaking. Treatment may include cautious supervision or surgery. The kind of treatment adopted, relies on the size of the aortic aneurysm and how quickly it is developing. CT scan assesses the abdomen in more detail in patients with a particular abdominal grievance. It also evaluates the form of the aneurysm with more inclusive anatomical details of the mesenteric and iliac arteries, and also offers superior imaging of suprarenal aneurysms. Helical CT angiography can represent complexities that establish consequently to the treatment of abdominal aortic aneurysms with endovascular stent grafts. Long-term follow-up is needed to decide the complete spectrum and frequency of complexities that may establish after a favorable fix at the beginning. Conservation of spinal cord blood supply at the time of descending thoracic (TAA) and thoracoabdominal aortic aneurysm (TAAA) surgery is mandatory to avoid neurologic complexities. Investigations have been conducted to determine whether the preoperative and postoperative existence or absence of collateral arteries discovered by magnetic resonance angiography (MRA) is connected with spinal cord function at the time of the intraoperative exclusion of the segmental supply to the Adamkiewicz artery.
The increasing predominance of hypertension and hyperlipidemia is set to drive the Abdominal Aortic Aneurysm Treatment Market. The surging count of smokers with elderly male smokers requiring ultrasound screening along with pre-existing CT scans is set to propel the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027. This represents the Abdominal Aortic Aneurysm Treatment Industry Outlook.
Abdominal Aortic Aneurysm Treatment Market Report Coverage
The report: “Abdominal Aortic Aneurysm Treatment Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the  Abdominal Aortic Aneurysm Treatment Market.
By Treatment: Open Surgical Repair (OSR), Endovascular Aneurysm Repair (EVAR). By Product: Stent Graft, Catheter. By End Use: Hospital, Ambulatory Surgical Center, Others. By Geography: North America (U.S, Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).
Inquiry Before Buying : https://www.industryarc.com/reports/request-quote?id=15315
Key Takeaways
Geographically, North America Abdominal Aortic Aneurysm Treatment Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the increasing predominance of abdominal aortic aneurysm requiring abdominal and pelvic CT scans for deciding the size and extent of an aneurysm in the North American region.
Abdominal Aortic Aneurysm Treatment Market growth is being driven by the rising pervasiveness of abdominal aortic aneurysm globally requiring abdominal and pelvic CT scans for deciding the size and extent of an aneurysm owing to altered lifestyle and the expanding population of the elderly. However, the cost and availability of treatment are some of the major factors hampering the growth of the Abdominal Aortic Aneurysm Treatment Market.
Abdominal Aortic Aneurysm Treatment Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the   Abdominal Aortic Aneurysm Treatment Market report.
Request For Sample : https://www.industryarc.com/pdfdownload.php?id=15315
Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Treatment:
The Abdominal Aortic Aneurysm Treatment Market based on treatment can be further segmented into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR). The Endovascular Aneurysm Repair (EVAR) Segment held the largest market share in 2021. This growth is owing to the enhanced patient survival offered by the Endovascular Aneurysm Repair technique. Endovascular repair (EVAR) is the positioning of a stent graft (fabric-covered tube) into the aneurysm by way of a tiny hole in the blood vessels in the groin. CT scan has been performed consequent to Endovascular Repair of Abdominal Aortic Aneurysms. The heightened demand for minimally invasive processes owing to minimized hospital stays and patient trauma in conjunction with the soaring success rate provided by technologically progressive devices is further propelling the growth of the Endovascular Aneurysm Repair (EVAR) segment.
Furthermore, the Open Surgical Repair (OSR) segment is estimated to grow with the fastest CAGR of 6.5% during the forecast period 2022-2027 owing to the superior outcomes of open surgical repair (OSR) in comparison with endovascular aneurysm repair (EVAR) for infrarenal abdominal aortic aneurysm (IRAAA) as per results of a retrospective cohort investigation issued in the Journal Vascular Brasileiro and CT scan is recommended with or without contrast at 5-year intervals after open surgical repair for thoracic aortic disease.
Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Product:
The Abdominal Aortic Aneurysm Treatment Market based on the product can be further segmented into Stent Graft and Catheter. The Stent Graft Segment held the largest market share in 2021. This growth is owing to the surging application of stent-grafts in Abdominal Aortic Aneurysm Treatment. Nellix and Ovation stent-grafts are novel generation prostheses that use polymer technology to treat abdominal aortic aneurysms. CT scan can be performed postoperatively. The benefits of endovascular repair with stent-graft are further propelling the growth of this segment.
Furthermore, the Catheter segment is estimated to grow with the fastest CAGR of 6.7% during the forecast period 2022-2027 owing to the surging application of Catheter-based aortic aneurysm repair attributed to it being a safe and preferred option of treatment for numerous patients with aortic aneurysms and investigations being conducted for intra-arterial catheter=directed CT angiography for evaluation of endovascular aortic aneurysm repair.
Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Geography:
The Abdominal Aortic Aneurysm Treatment Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Abdominal Aortic Aneurysm Treatment Market) held the largest share with 39% of the overall market in 2021. The growth of this region is owing to the increasing predominance of abdominal aortic aneurysms in the region. The continued technological upgrades in the healthcare sector and the increasing predominance of cardiovascular diseases requiring CT scans are further driving the growth of the Abdominal Aortic Aneurysm Treatment Market in the North American region.
Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like expanding population of the elderly being more susceptible to incessant ailments requiring the application of CT scans in the Asia-Pacific region. The supportive government policies increased spending on healthcare, and proliferating modernization of medical infrastructure are further fuelling the progress of the   Abdominal Aortic Aneurysm Treatment Market in the Asia-Pacific region.
Abdominal Aortic Aneurysm Treatment Market Drivers
Surging Applications Of Abdominal Computed Tomography Angiography Are Projected To Drive The Growth Of   Abdominal Aortic Aneurysm Treatment Market:
Computed tomography angiography (CTA) transformed vascular imaging when vessels tinier than 1 mm in diameter were imaged with single-slice spiral CT. Other than its restricted invasiveness, the benefits of CT Angiography involve reduced cost and a possible minimization in the total volume of contrast material administered. With the quickest scanners presently accessible (16, 64, 256 slices), abdominal Computed Tomography Angiography may be carried out with as little as 50 mL of contrast material utilizing a saline flush. Typical abdominal uses of CTA involve assessment of the abdominal aorta, preoperative and postoperative evaluation for renal and liver transplantation, preoperative planning for hepatic segmentectomy and pancreatic surgery, mesenteric ischemia, and gastrointestinal (GI) hemorrhage. Additional uses involve cholecystectomy and splenectomy planning, and evaluation for renal arterial disease in the assessment of hypertension. The protocols for every use should be separately tailor-made to optimize imaging of the targeted vascular structures. CTA is typically the approved imaging modality for the assessment of the abdominal aorta in intense and non-emergent settings. The surging applications of abdominal computed tomography angiography are therefore fuelling the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027.
Heightened Applications Of Magnetic Resonance Angiography For The Treatment of Infrarenal Abdominal Aortic Aneurysms Are Expected To Boost The Demand Of Abdominal Aortic Aneurysm Treatment Market:
Magnetic resonance angiography (MRA) like Computed Tomography Angiography (CTA) has the advantage of being able to envision the complete aorta inclusive of its branch vessels. Dissimilar to CTA, it does not reveal the patient to radiation nor is iodinated contrast dye needed. This can be more attractive for patients with a contrast allergy or renal inadequacy. In patients with kidney ailments, non-gadolinium contrast agents prevail. Blood pool contrast agents, like ferumoxytol, may be utilized to improve MRA to offer good imaging quality. Additionally, typical investigations have discovered that non-contrast magnetic resonance imaging (MRI), when teamed with electrocardiographic- and cardiac-gated methods, has identical image quality in comparison with contrast-enhanced MRA images of the aorta. Time-resolved 3D phase-contrast MRI with three-directional velocity encoding, also termed as 4D flow MRI has currently emerged as an instrument to more thoroughly assess abdominal circulation. 4D flow MRI may permit for more precise aortic modeling in the future owing to its capability to concurrently assess vascular anatomy and hemodynamics. MRA is commensurate to CTA with respect to the precision of AAA assessments. The heightened applications of Magnetic Resonance Angiography for the treatment of Infrarenal Abdominal Aortic Aneurysms are driving the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027.
Abdominal Aortic Aneurysm Treatment Market Challenges
Handling Of The Ruptured Abdominal Aortic Aneurysm By Paramedics Poses Challenges To The Growth Of The Abdominal Aortic Aneurysm Treatment Market:
The ruptured abdominal aortic aneurysm is a time-critical medical emergency needing timely surgical intervention to provide any opportunity of survival. Even when identified early, 90% of patients will endure an out-of-hospital cardiac arrest prior to landing at the emergency department and of those who arrive at the theatre, only 40% will survive. The ruptured AAA needs urgent surgical intervention. These kinds of patients cannot be stabilized in the prehospital environment and endeavors to do so will be pointless and are likely to jeopardize patient care. The paramedic practitioners handling of the ruptured AAA must involve, and sometimes be restricted to, accelerated identification and practical transport to a hospital with competence in handling vascular emergencies. Intravascular access must not defer transport to a suitable receiving facility. Prehospital interventions like fluid administration can minimize the occurrence of post-operative complexities like acute renal failure. However, this should not be utilized to legitimize numerous cannulation efforts on the scene. The establishment of a fast-track pathway for direct admission to theatre could possibly save lives. Further research and the establishment of such a pathway should include all members of the multi-disciplinary team. These issues are hampering the growth of the Abdominal Aortic Aneurysm Treatment Market.
Buy Now : https://www.industryarc.com/purchasereport.php?id=15315
Abdominal Aortic Aneurysm Treatment Market - Landscape:
Product launches, mergers and acquisitions, joint ventures, and R&D Activities are key strategies adopted by players in the   Abdominal Aortic Aneurysm Treatment Market. Key companies of this market are:
Novartis Pharmaceuticals
Merck
Cook Medical Inc.
Endologix Inc.
W.L.Gore & Associates
Medtronic Plc.
Cardinal Health Inc.
Lombard Medical, Inc.
Terumo Aortic
Cardiatis S.A.
Recent Developments
In April 2021, Cardinal Health introduced Outcomes™, a digital ecosystem linking pharmacists, payers, and pharmaceutical firms to diminish the challenges of medicine non-adherence. Outcomes convey digital health solutions for personalized medication therapy administration, digital patient engagement, and tele pharmacy, through its Connect™ platform. Therefore, these three customer groups can enhance patient adherence to medicine, fuel superior health outcomes for patients, and reduce the cost of care.
In July 2020, Novartis declared a novel initiative to assist patients in low-income and lower-middle-income countries (LIC; LMIC) access economical medications to treat the principal symptoms of COVID-19 – a crucial requirement in the absence of a vaccine or curative treatment. Inflammation and respiratory issues connected with COVID-19 may bring about serious medical complexities and may result in demise in certain people, establishing an enormous burden on delicate healthcare systems. The Novartis COVID-19 portfolio involves 15 medications from its Sandoz division for gastrointestinal sickness, intense respiratory symptoms, pneumonia, and septic shock.
In March 2020, Endologix® Inc. declared that it has accepted an endorsement from the U.S. Food and Drug Administration (FDA) for the Alto™ Abdominal Stent Graft System (Alto). The firm accepted endorsement based on its supervisory compliance that involves the ELEVATE Investigational Device Exemption (IDE) clinical investigation. Agreeable to the terms of endorsement, the earliest 100 patients consequent to commercial introduction will be involved in a post-approval imaging study to decide constancy in instrument choice between Endologix’s internal imaging services and those of the implanting physicians.
Related Reports-
Endovascular Abdominal Aortic Aneurysm Repair Devices Market
Report Code: HCR 46793
Aortic Aneurysm Market
Report Code: HCR 81184
For more Lifescience and Healthcare related reports, please
click here
0 notes